XML 31 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Consolidated net loss $ (433,000) $ (496,000)
Adjustments to reconcile consolidated net loss to net cash and cash equivalents provided by operating activities:    
Depreciation and amortization expense 126,000 108,000
Stock-based compensation expense 557,000 544,000
Operating lease non-cash expense 66,000 60,000
Accretion on marketable securities, net (23,000) (34,000)
Other adjustments (11,000) 5,000
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 407,000 87,000
Prepaid expenses and other current assets (34,000) (24,000)
Deferred cost of revenue (24,000) (93,000)
Other assets (1,000) (7,000)
Accounts payable (32,000) 12,000
Accrued expenses and other current liabilities 68,000 8,000
Developer exchange liability (75,000) (25,000)
Deferred revenue 401,000 538,000
Operating lease liabilities (72,000) (53,000)
Other long-term liabilities 27,000 13,000
Net cash and cash equivalents provided by operating activities 947,000 643,000
Cash flows from investing activities:    
Acquisition of property and equipment (55,000) (40,000)
Purchases of intangible assets (2,000) 0
Payments related to business combinations, net of cash acquired (6,000) 0
Purchases of investments (2,983,000) (2,611,000)
Maturities of investments 1,649,000 1,809,000
Sales of investments 577,000 412,000
Other investing activities 3,000 0
Net cash and cash equivalents used in investing activities (817,000) (430,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock 34,000 64,000
Repurchases of common stock (375,000) 0
Net cash and cash equivalents provided by (used in) financing activities (341,000) 64,000
Effect of exchange rate changes on cash and cash equivalents (3,000) 6,000
Net increase/(decrease) in cash and cash equivalents (214,000) 283,000
Cash and cash equivalents    
Beginning of period 1,205,000 712,000
End of period 991,000 995,000
Supplemental disclosure of noncash investing and financing activities:    
Property and equipment additions in accounts payable, accrued expenses and other current liabilities, and other long-term liabilities 21,000 36,000
Fair value of common stock and unregistered restricted stock units issued and additional cash consideration payable associated with business combinations 17,000 0
Repurchases of common stock included in accrued liabilities $ 5,000 $ 0